Paradigm Biopharmaceuticals | PAR - Net Income

Stock Price
0.20
Daily Change
0.01 2.63%
Monthly
-25.00%
Yearly
-33.90%
Q2 Forecast
0.22

Paradigm Biopharmaceuticals reported AUD-23.24M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Avita Medical AUD -11.62M 1.7M Dec/2025
Medical Developments International AUD -226K 121K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025